Keywords
Malaria, adults, mortality, Sierra Leone
Malaria, adults, mortality, Sierra Leone
The revised article incorporates the suggestions of the reviewers including new wording and additional data except where the suggested data were not collected or were unavailable (e.g., sickle cell disease data were unavailable for most patients).
See the authors' detailed response to the review by Sheikh Omar Bittaye
See the authors' detailed response to the review by Peter Okpeh Amede
It remains uncertain whether malaria is an important cause of death among adults living in endemic areas1. One of the reasons for this uncertainty is that many countries with a high burden of malaria do not have a vital registration system. Malaria statistics for African countries published by the World Health Organization are based on the results of verbal autopsy in children under the age of five and provide little information on malaria mortality in adults2.
We further explored the importance of malaria as a cause of death in adults in Sierra Leone by performing a chart review of all patients admitted to one of three adult medical wards at Bo Government Hospital during the 2019 calendar year.
We conducted a retrospective hospital-based chart review of adults (age ≥18) admitted to Bo Government Hospital from 1st January to 31st December 2019. Bo Government Hospital is major regional hospital in Southern Province, Sierra Leone and provides adult, maternal and pediatric care services to the city of Bo and surrounding districts. Three investigators (SK, AA, IB) extracted data from the medical charts of unselected consecutive adults admitted with a laboratory diagnosis of malaria during 2019 as part of the Countrywide Mortality Surveillance for Action (COMSA) Sierra Leone Project3. The study included patients admitted over a 12-month period to provide a representative sample in view of the seasonal pattern of malaria. Eligible patients were identified based on review of laboratory results as documented in their medical charts and there were no exclusion criteria. Data extracted included age, sex (female/male), results of diagnostic testing for malaria (rapid diagnostic test, thick and thin film), information on the severity of malaria as defined by the World Health Organization criteria4, and patient outcome (discharged alive or died in hospital).
Data were summarised as counts and mean and standard deviation for continuous variables, and number and percentage for categorical variables. The significance of any differences in proportions was evaluated with a chi square test and a 2-sided p value <0.05 was considered statistically significant. Analyses were performed using SAS version 9.4.
All investigators are listed as authors and had complete access to study data.
Ethical permission was granted by the Office of the Sierra Leone Ethics and Scientific Review Committee (dated March 15, 2022). Individual patient consent was not required because the study involved a retrospective chart review.
Results are summarised in Table 15. Of 893 adult admissions, 149 (59% female, mean age 58.5 years [SD 13.0]) had a laboratory diagnosis of malaria based on positive rapid diagnostic test or parasitemia on blood film. Of these, 20 (13.4%) were categorized as having severe malaria.
Characteristic and outcome | Admissions with malaria (n=149) |
---|---|
Age, mean (SD) | 58.5 (SD 13.0) |
Age < 60 | 61 (52.6%) |
Age ≥ 60 | 55 (47.4%) |
Female, n (%) | 86 (59.3%) |
Hypertension | 84 (66.1%) |
Malaria severity, n (%) | |
Non-severe | 129 (86.6%) |
Severe | 20 (13.4%) |
Deaths, n (%)† | 22 (14.8%) |
Severe | 6 (30.0%) |
Non-severe | 16 (12.4%) |
Of 149 patients with a malaria diagnosis, 22 (14.8%) died. There were no significant differences in age, sex or proportion of patients with hypertension among those whose chart review included criteria for severe malaria (including prostration, severe anaemia, jaundice, reduced level of consciousness, seizures, shock) compared with those who did not. Mortality was significantly higher among patients with severe malaria compared with those who had non-severe malaria (6/20 [30%] versus 16/129 [12.4%], p=0.031).
The results of our chart review indicate that 1 in 7 adult patients admitted to Bo Government Hospital with laboratory confirmed malaria died. As expected, the mortality rate was highest in patients admitted with severe malaria, but most deaths still occurred in patients who did not have severe disease.
The large number of malaria admissions and high malaria mortality among adults observed during 2019 at Bo Government Hospital is consistent with emerging data that malaria is a significant contributor to adult mortality. The Sierra Leone Sample Registration System (SL-SRS) of births and deaths performed between September 1, 2019 and December 15, 2020 found that malaria accounted for 22% of deaths under the age of 70 years and was a leading cause of death in adults4. Bittaye and colleagues reported 9.9% mortality in 131 adults (age 15–90) hospitalized with malaria during 2020–2022 in the Gambia, with all deaths occurring in patients with severe malaria6. Boushab and colleagues reported 14.1% mortality in 99 adults (age >15 years) hospitalized with severe malaria during 2016–2019 in Mauritania7. The Indian Million Death Study (MDS) suggested a higher adult mortality rate than expected, especially in persons aged over 45 years8. Similar results were reported by the International Network for Demographic Evaluation of Populations and their Health (INDEPTH) Network9.
Our data have some limitations. First, rapid diagnostic tests for malaria may be associated with both false positive and false negative results. It is likely that some adults had other underlying acute medical conditions leading to hospitalization but were categorized as having malaria due to an incidental finding of parasitemia on rapid testing or blood film examination. Second, classification of the severity of malaria was limited by lack of complete medical information, and it is possible that misclassification of the severity of disease explains the higher-than-expected mortality rate in those with non-severe malaria. Third, we did not have access to treatment information or the possible presence of drug resistance and are therefore unable to determine the reasons for the high adult malaria mortality in this study. It is also unclear whether concomitant infections, such as bacteremia, or other conditions may have contributed to malaria mortality seen in our study. Finally, our study was performed in a single regional hospital and the high mortality in hospitalized patients may not be generalizable to other hospitals in Sierra Leone.
In conclusion, our data demonstrate that the burden of adult malaria mortality in Bo Government Hospital, Sierra Leone is high. Further studies are needed to explore the reasons for the high mortality and more effective prevention and treatment strategies should be urgently implemented.
DRYAD: Health records from hospitalized adults with malaria during 2019 at Bo Government Hospital, Sierra Leone. https://doi.org/10.5061/dryad.5hqbzkh9s5.
This project contains the following underlying data:
Data file 1: data extracted from retrospective medical chart review
Data file 2: data dictionary
README file: description of dataset
Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
Views | Downloads | |
---|---|---|
Gates Open Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Infectious disease, hepatology, Gastroenterology
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
No
If applicable, is the statistical analysis and its interpretation appropriate?
No
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: No competing interests were disclosed.
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Partly
Are the conclusions drawn adequately supported by the results?
Yes
References
1. Bittaye SO, Jagne A, Jaiteh LE, Nadjm B, et al.: Clinical manifestations and outcomes of severe malaria in adult patients admitted to a tertiary hospital in the Gambia.Malar J. 2022; 21 (1): 270 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Infectious disease, hepatology, Gastroenterology
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 2 (revision) 14 Aug 23 |
read | read |
Version 1 15 Mar 23 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with Gates Open Research
Already registered? Sign in
If you are a previous or current Gates grant holder, sign up for information about developments, publishing and publications from Gates Open Research.
We'll keep you updated on any major new updates to Gates Open Research
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)